Companies Dominating the Propofol Landscape
- Pfizer Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Bachem Holding AG
- Porton Fine Chemicals Ltd.
- SI Group, Inc.
- AstraZeneca plc
- Fresenius Kabi AG
- Baxter Healthcare Corporation
- Teva Pharmaceutical Industries Ltd.
- Hikma Pharmaceuticals PLC
- Mylan N.V.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of propofol is assessed at USD 1.09 billion.
Propofol Market size was over USD 1.04 billion in 2024 and is projected to reach USD 2.01 billion by 2037, witnessing around 5.2% CAGR during the forecast period i.e., between 2025-2037.
North America industry is expected to dominate majority revenue share by 2037, on the back of increase in the number of well-established healthcare facilities, high adoption of minimally invasive surgical procedures and easy availability of drugs in the region.
The major players in the market are Pfizer Inc., Bachem Holding AG, Porton Fine Chemicals Ltd., SI Group, Inc., AstraZeneca plc, and others.
